Company Biotoscana Investments S.A.
Equities
GBIO33
BRGBIOBDR008
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Claudio Coracini
CEO | Chief Executive Officer | - | 20/10/19 |
Director of Finance/CFO | - | 14/08/19 | |
Ivan French
CTO | Chief Tech/Sci/R&D Officer | - | 14/12/17 |
Román Saglio
SAM | Sales & Marketing | 54 | 31/12/14 |
Renato de Giorgi
PRN | Corporate Officer/Principal | 55 | 31/12/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Lande
BRD | Director/Board Member | 61 | 24/11/19 |
Samira Sakhia
CHM | Chairman | 55 | 28/11/19 |
Gaëlle Lamotte
BRD | Director/Board Member | - | 24/11/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 106,622,306 | 104,688,619 ( 98.19 %) | 490,236 ( 0.4598 %) | 98.19 % |
Company contact information
Biotoscana Investments SA
WTC Montevideo Free Zone Dr Luis Bonavita, 1294
11300, Montevideo
+
http://www.grupobiotoscana.com![address Biotoscana Investments S.A.(GBIO33)](https://cdn.zonebourse.com/static/address/37215933.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+5.90% | 71.83B | |
+22.78% | 9.56B | |
+30.09% | 4.85B | |
-21.31% | 4.48B | |
+24.78% | 3.9B | |
+11.03% | 2.01B | |
-2.11% | 1.99B | |
-36.28% | 1.89B | |
-43.19% | 1.77B |